EC Healthcare (2138.HK)
HKD 0.7
(-1.41%)
HKD 0.7
(-1.41%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 2.97 Billion HKD | -5.48% |
| 2022 | 3.14 Billion HKD | 25.19% |
| 2021 | 2.51 Billion HKD | 16.22% |
| 2020 | 2.15 Billion HKD | 55.85% |
| 2019 | 1.38 Billion HKD | 17.33% |
| 2018 | 1.18 Billion HKD | 3.11% |
| 2017 | 1.14 Billion HKD | 179.79% |
| 2016 | 409.4 Million HKD | -3.51% |
| 2015 | 424.28 Million HKD | -8.7% |
| 2014 | 464.71 Million HKD | -5.99% |
| 2013 | 494.31 Million HKD | 15.34% |
| 2012 | 428.55 Million HKD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 Q4 | 2.97 Billion HKD | -6.11% |
| 2023 Q2 | 3.16 Billion HKD | 0.67% |
| 2023 FY | 2.97 Billion HKD | -5.48% |
| 2022 Q4 | 3.14 Billion HKD | 11.91% |
| 2022 FY | 3.14 Billion HKD | 25.19% |
| 2022 Q2 | 2.8 Billion HKD | 11.86% |
| 2021 Q4 | 2.51 Billion HKD | 22.67% |
| 2021 Q2 | 2.04 Billion HKD | -5.25% |
| 2021 FY | 2.51 Billion HKD | 16.22% |
| 2020 Q2 | 1.41 Billion HKD | 1.88% |
| 2020 Q4 | 2.15 Billion HKD | 52.98% |
| 2020 FY | 2.15 Billion HKD | 55.85% |
| 2019 FY | 1.38 Billion HKD | 17.33% |
| 2019 Q4 | 1.38 Billion HKD | 6.05% |
| 2019 Q2 | 1.3 Billion HKD | 10.63% |
| 2018 Q4 | 1.18 Billion HKD | 3.1% |
| 2018 FY | 1.18 Billion HKD | 3.11% |
| 2018 Q2 | 1.14 Billion HKD | 0.0% |
| 2017 Q4 | 1.14 Billion HKD | 78.0% |
| 2017 FY | 1.14 Billion HKD | 179.79% |
| 2017 Q2 | 643.5 Million HKD | 57.18% |
| 2016 Q2 | 424.22 Million HKD | -0.02% |
| 2016 FY | 409.4 Million HKD | -3.51% |
| 2016 Q4 | 409.4 Million HKD | -3.49% |
| 2015 FY | 424.28 Million HKD | -8.7% |
| 2015 Q4 | 424.28 Million HKD | -9.69% |
| 2015 Q2 | 469.78 Million HKD | 2.46% |
| 2014 FY | 464.71 Million HKD | -5.99% |
| 2014 Q4 | 458.51 Million HKD | 0.0% |
| 2013 FY | 494.31 Million HKD | 15.34% |
| 2012 FY | 428.55 Million HKD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Natural Beauty Bio-Technology Limited | 308.05 Million HKD | -864.193% |
| Innovative Pharmaceutical Biotech Limited | 1.06 Billion HKD | -179.269% |
| China Overseas Nuoxin International Holdings Limited | 109.1 Million HKD | -2622.508% |
| Prosperous Future Holdings Limited | 177.1 Million HKD | -1577.093% |
| Huasheng International Holding Limited | 675.58 Million HKD | -339.663% |
| Fourace Industries Group Holdings Limited | 61.8 Million HKD | -4705.894% |
| Evergreen Products Group Limited | 786.46 Million HKD | -277.675% |
| Ming Fai International Holdings Limited | 772.01 Million HKD | -284.746% |
| Blue Moon Group Holdings Limited | 1.61 Billion HKD | -83.596% |
| SuperRobotics Holdings Limited | 172.27 Million HKD | -1624.182% |
| Takbo Group Holdings Limited | 42.84 Million HKD | -6831.977% |
| Hyfusin Group Holdings Limited | 181.34 Million HKD | -1537.891% |